Results 91 to 100 of about 5,411 (177)

Cataract Formation due to use of Deferiprone in a Patient with Thalassemia Major

Çukurova Üniversitesi Tıp Fakültesi Dergisi, 2015
Thalassemias are a heterogeneous group of autosomal recessive diseases characterized by hypochromic microcytic anemia and occur as a result of defective synthesis of one or more hemoglobin chains. In patients, life-threatening clinical manifestations may
Barbaros sahin Karagun, Yurdanur Kilinc, ilgen sasmaz, Ali Bulent Antmen   +3 more
doaj  

Prophylactic use of deferiprone (L1) and magnetic resonance imaging T2* or T2 for preventing heart disease in thalassaemia [PDF]

, 2004
Annita Kolnagou, Charis Fessas, Antonis Papatryphonas, Charalambos Economides, George J. Kontoghiorghes   +4 more
openalex   +1 more source

P2‐048: DEFERIPRONE AND EFONIDIPINE EQUALLY ATTENUATED BRAIN IRON DEPOSITION AND IRON‐MEDIATED BRAIN TOXICITY IN WILD‐TYPE AND THALASSEMIC MICE [PDF]

, 2019
Jirapas Sripetchwandee, Juthamas Khamseekaew, Somdet Srichairatanakoole, Nipon Chattipakorn, Suthat Fucharoen, Siriporn C. Chattipakorn   +5 more
openalex   +1 more source

Deferiprone Treatment in Aged Transgenic Tau Mice Improves Y-Maze Performance and Alters Tau Pathology [PDF]

, 2021
Shalini S. Rao, Larissa Lago, Irene Volitakis, Jay J. Shukla, Gawain McColl, David I. Finkelstein, Paul A. Adlard   +6 more
openalex   +1 more source

Treating thalassemia major-related iron overload: the role of deferiprone

, 2012
Vasili Berdoukas, Farmaki, Carson, Wood, Coates   +4 more
openalex   +2 more sources

Deferiprone Protects against Photoreceptor Degeneration Induced by Tunicamycin in the Rat Retina

, 2015
Yousuke Shirai, Asami Mori, Tsutomu Nakahara, Kenji Sakamoto, Kunio Ishii   +4 more
openalex   +2 more sources

Unimodal Imaging of Monovalent Metal-Chelator Complexes and Lipids by MALDI Imaging Mass Spectrometry. [PDF]

J Am Soc Mass Spectrom
Luchini KA, Breidenbach JD, McBride EM, Mach PM, Rivera ES.   +4 more
europepmc   +1 more source

Effect of Deferiprone versus Deferiprone with Deferasirox in Iron Chelation Therapy of Thalassemia Children

, 2018
Dr Syeda Jarka Jahir
openalex   +1 more source

Combination‐therapy with concurrent deferoxamine and deferiprone is effective in treating resistant cardiac iron‐loading in aceruloplasminaemia [PDF]

, 2015
Mohsin Badat, Banu Kaya, Paul Telfer
openalex   +1 more source

Endocrine complications in patients with β-thalassemia major receiving iron-chelation therapy. [PDF]

Ther Adv Endocrinol Metab
Al-Sanabra OM, Abbas MA, Hazàa AA, Hazà WJ.   +3 more
europepmc   +1 more source